BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3492025)

  • 21. Immune complexes in rheumatoid arthritis sera and synovial fluids: a comparison of three methods.
    Halla JT; Volanakis JE; Schrohenloher RE
    Arthritis Rheum; 1979 May; 22(5):440-8. PubMed ID: 444313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibronectin binding with immunoglobulin aggregates and its association with rheumatic disorders.
    Carter SD; Scott DL; Elson CJ
    Br J Rheumatol; 1986 Nov; 25(4):353-8. PubMed ID: 3490895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
    Perego R; Vezzoli S; Manfredi W; Bigi G; Procaccia S
    Boll Ist Sieroter Milan; 1983 Nov; 62(5):462-8. PubMed ID: 6608359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties and reactivity of immune complexes in rheumatoid synovial fluid.
    Mochan E; Passon TJ
    Rheumatol Int; 1986; 6(3):103-9. PubMed ID: 3489272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
    Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
    Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of immune complexes by the classical pathway.
    Whaley K; Ahmed AE
    Behring Inst Mitt; 1989 Jul; (84):111-20. PubMed ID: 2529842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and analysis of immune complexes from sera of patients with polymyalgia rheumatica and giant cell arteritis.
    Smith AJ; Kyle V; Cawston TE; Hazleman BL
    Ann Rheum Dis; 1987 Jun; 46(6):468-74. PubMed ID: 2820320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of immunoglobulins and immune complexes to cartilage derived extracts.
    Alomari WR; Archer JR; Brocklehurst R; Currey HL
    Clin Exp Immunol; 1983 Dec; 54(3):716-22. PubMed ID: 6606513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of action of an inhibitor of complement-mediated prevention of immune precipitation.
    Ahmed AE; Veitch J; Whaley K
    Immunology; 1990 Jun; 70(2):139-44. PubMed ID: 2373514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased C1q binding immune complexes in Felty's syndrome: comparison with uncomplicated rheumatoid arthritis.
    Hurd ER; Chubick A; Jasin HE; Ziff M
    Arthritis Rheum; 1979 Jul; 22(7):697-702. PubMed ID: 454498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis.
    Naama JK; Mitchell WS; Whaley K
    Clin Exp Immunol; 1983 Nov; 54(2):429-38. PubMed ID: 6652966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Citrullinated antigens as C1q-binding and monoclonal rheumatoid factor (mRF)-binding peptides in synovial fluids from rheumatoid arthritis patients.
    Sawada T; Kanzaki T; Hashimoto S; Suzuki A; Yamada R; Odawara M; Yamamoto K
    Clin Exp Rheumatol; 2009; 27(6):989-92. PubMed ID: 20149318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
    Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating and intra-articular immune complexes in rheumatoid arthritis: a comparative study of the C1q binding and monoclonal rheumatoid factor assays.
    Roberts-Thomson PJ; Neoh SH; Bradley J; Milazzo SC
    Ann Rheum Dis; 1980 Oct; 39(5):438-44. PubMed ID: 7436574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity.
    Halla JT; Volanakis JE; Hardin JG; Schrohenloher RE
    Clin Exp Immunol; 1978 Nov; 34(2):226-34. PubMed ID: 737907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of immune complexes in the activation of the first component of human complement.
    Ziccardi RJ
    J Immunol; 1984 Jan; 132(1):283-8. PubMed ID: 6317744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.